Cargando…
EXCEPTIONAL AGGRESSIVENESS OF CEREBRAL CAVERNOUS MALFORMATION DISEASE ASSOCIATED WITH PDCD10 MUTATIONS
PURPOSE: The phenotypic manifestations of cerebral cavernous malformation (CCM) disease caused by rare PDCD10 mutations have not been systematically examined, and a mechanistic link to Rho kinase (ROCK) mediated hyperpermeability, a potential therapeutic target, has not been established. METHODS: We...
Autores principales: | Shenkar, Robert, Shi, Changbin, Rebeiz, Tania, Stockton, Rebecca A., McDonald, David A., Mikati, Abdul Ghani, Zhang, Lingjiao, Austin, Cecilia, Akers, Amy L., Gallione, Carol J., Rorrer, Autumn, Gunel, Murat, Min, Wang, De Souza, Jorge Marcondes, Lee, Connie, Marchuk, Douglas A., Awad, Issam A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329119/ https://www.ncbi.nlm.nih.gov/pubmed/25122144 http://dx.doi.org/10.1038/gim.2014.97 |
Ejemplares similares
-
Propranolol as therapy for cerebral cavernous malformations: a cautionary note
por: Shenkar, Robert, et al.
Publicado: (2022) -
Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations
por: Ressler, Andrew K., et al.
Publicado: (2023) -
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity
por: Stockton, Rebecca A., et al.
Publicado: (2010) -
Phenotypic Characterization of Murine Models of Cerebral Cavernous Malformations
por: Zeineddine, Hussein A., et al.
Publicado: (2018) -
Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation
por: Li, Ying, et al.
Publicado: (2023)